Justin Moyers

Hematology | Oncology
11818 Wilshire Blvd
Los Angeles, CA 90025

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Single-cell transcriptomic analysis reveals tumor-immune determinants of lymph node colonization and progression in thyroid cancer.

Single-cell transcriptomic analysis reveals tumor-immune determinants of lymph node colonization and progression in thyroid cancer.

Journal: Science advances
Published: July 03, 2026

Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review.

Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review.

Journal: Human vaccines & immunotherapeutics
Published: May 21, 2026

Factor V Leiden in Head and Neck Reconstruction: Institutional Experience and Protocol.

Factor V Leiden in Head and Neck Reconstruction: Institutional Experience and Protocol.

Journal: The Journal of craniofacial surgery
Published: May 14, 2026

Pertuzumab and Trastuzumab in Patients With ERBB2/3-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study.

Pertuzumab and Trastuzumab in Patients With ERBB2/3-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study.

Journal: JCO precision oncology
Published: April 30, 2026

Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Journal: JCO precision oncology
Published: April 22, 2026

Cancer in public figures, 2010-2020.

Cancer in public figures, 2010-2020.

Journal: ESMO real world data and digital oncology
Published: February 06, 2026

Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Journal: JCO precision oncology
Published: January 15, 2026

Evolving Use of Circulating Tumor DNA for HPV+ Oropharyngeal Carcinoma: Consensus Recommendations From the California Head and Neck Consortium.

Evolving Use of Circulating Tumor DNA for HPV+ Oropharyngeal Carcinoma: Consensus Recommendations From the California Head and Neck Consortium.

Journal: JCO oncology practice
Published: December 04, 2025

Detection of Human Papillomavirus (HPV) in HPV-Associated Oropharyngeal Squamous Cell Carcinoma: A Review of Diagnostic Approach and Its Importance for the Head and Neck Oncologist.

Detection of Human Papillomavirus (HPV) in HPV-Associated Oropharyngeal Squamous Cell Carcinoma: A Review of Diagnostic Approach and Its Importance for the Head and Neck Oncologist.

Journal: Cancers
Published: November 16, 2025

Incorporation of grade into stage in oral cavity squamous cell carcinoma: A novel staging schema.

Incorporation of grade into stage in oral cavity squamous cell carcinoma: A novel staging schema.

Journal: Oral oncology
Published: November 11, 2025

Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors.

Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors.

Journal: ESMO open
Published: February 28, 2025

A review of histopathologic assessment for head and neck oncologists.

A review of histopathologic assessment for head and neck oncologists.

Journal: Oral oncology
Published: December 23, 2024
Showing 1-12 of 42

Last Updated: 09/26/2026